Lost Money on Zymeworks Inc.(ZYME)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationAccesswire • 05/03/24
ATTENTION Zymeworks Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your RightsAccesswire • 05/02/24
ATTENTION ZYME SHAREHOLDERS: Investors who Lost Money on Zymeworks Inc. are Urged to Contact Levi & Korsinsky about an Ongoing InvestigationAccesswire • 04/19/24
ZYME ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Zymeworks Inc.Accesswire • 04/18/24
Levi & Korsinsky Reminds Shareholders of an Investigation into Zymeworks Inc. (ZYME) Regarding Potential Securities Fraud AllegationsAccesswire • 04/16/24
Zymeworks Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - ZYMEAccesswire • 04/12/24
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024GlobeNewsWire • 04/11/24
Did Zymeworks Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - ZYMEAccesswire • 04/10/24
Zymeworks (ZYME) Loses -13.41% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 04/10/24
Zymeworks Inc. Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - ZYMEAccesswire • 04/08/24
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual MeetingGlobeNewsWire • 04/08/24
Zymeworks Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - ZYMEAccesswire • 04/04/24
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of DirectorsGlobeNewsWire • 03/28/24
Zymeworks (ZYME) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 03/22/24
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual MeetingGlobeNewsWire • 03/05/24
Analysts Estimate Zymeworks Inc. (ZYME) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 02/28/24